NCT06393712
- Conditions
- Amyloidosis, Brain Diseases, Cardiovascular Diseases, +10 more
- Locations
-
- Clinical Trial Site Los Angeles, California, United States
- Clinical Trial Site Orange, California, United States
- Clinical Trial Site Palo Alto, California, United States
- Clinical Trial Site Sacramento, California, United States